X0306 4 2021-03-09 0 0001420800 Colfax CORP CFX 0001205249 PRYOR DANIEL A 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR ANNAPOLIS JUNCTION MD 20701 0 1 0 0 EVP, Strategy & Business Dev. Common stock, par value $.001 2021-03-09 4 A 0 21689 0.00 A 145035 D Common stock, par value $.001 2021-03-09 4 A 0 55284 0.00 A 200319 D Common stock, par value $.001 2021-03-10 4 S 0 4004 47.42 D 196315 D Common stock, par value $.001 2021-03-10 4 S 0 6157 47.92 D 190158 D Common stock, par value $.001 2021-03-10 4 S 0 5500 47.27 D 184658 D Common stock, par value $.001 2021-03-10 4 S 0 20401 47.86 D 164257 D Common stock, par value $.001 2312 I By 401K Plan Common stock, par value $.001 1000 I By trust for daughter Common stock, par value $.001 1000 I By trust for daughter Common stock, par value $.001 1000 I By trust for son Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.65 to $47.64, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (3) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.65 to $48.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (4) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.53 to $47.52, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (5) to this Form 4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.53 to $48.20, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (6) to this Form 4. /s/ Bradley Tandy, Attorney-in-Fact 2021-03-11